BioSpace News Archive

Zomedica Corp. provided a business update and will be hosting a conference call.

Apollomics Inc. (“Apollomics” or the “Company”) today announced that Guo-Liang Yu, Ph.D., Chairman and Chief Executive Officer of Apollomics, and Sanjeev Redkar, Ph.D., President of Apollomics, will participate in a Fireside Chat at the B. Riley Securities 2024 Virtual Oncology Conference on Thursday, January 18, 2024 at 11:00 a.m. ET.

Amplia Therapeutics Limited, is pleased to announce that the US FDA have cleared Amplia’s IND application for a trial of Amplia’s best-in-class focal adhesion kinase inhibitor narmafotinib in pancreatic cancer.

Shanghai Junshi Biosciences Co., Ltd announced the publication of results from the prespecified interim analysis for event-free survival in patients with stage III non-Small Cell Lung Cancer of NEOTORCH in theJournal of the American Medical Association.

Eurofins CDMO Alphora Inc., a Contract Drug and Manufacturing Organization based in Mississauga, Canada, is excited to announce the successful completion of its pilot-scale biologics development facility.

Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for patients with below-knee peripheral arterial disease were performed successfully using its Finesse InjectableTM balloon catheter platform.

SYNAPS Dx (SDx) today appointed an accomplished group of physicians, neuroscientists and esteemed leaders in neurodegenerative disease to its newly formed Scientific Advisory Board (SAB), reinforcing its commitment and position as an innovator and first-mover in the AD diagnostics industry.

Transformational year highlighted by record surgical volume, record growth, and publication of Level 1 clinical evidence

eClinical Solutions today announced the results from its 2024 Industry Outlook, an annual report synthesizing research with 77 professionals working across clinical operations, data management, statistical programming, and biometrics functions to reveal insights on the most pressing trends, challenges, and opportunities shaping the clinical data landscape.

National Research Corporation, dba NRC Health, has announced the following appointments of four newly created executive officer positions.